BROWNSTEIN HYATT FARBER SCHRECK, LLP for JOHNSON & JOHNSON SERVICES, INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 18, 2010 | $90,000 | Replaced |
| 3rd Quarter - Amendment | Dec 13, 2016 | $90,000 | Yes |
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
General corporate tax issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATE MCCANLESS BLANKENBURG | — |
| ALEXANDER DAHL | — |
| MICHAEL B LEVY | — |
Consumer Issues/Safety/Products CSP
Safety of consumer products Text 4 Baby
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATE MCCANLESS BLANKENBURG New | — |
| REGINA E MAHONY | — |
Torts TOR
H.R.4115-The Open Access to Courts Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM MOSCHELLA | — |
Law Enforcement/Crime/Criminal Justice LAW
Pseudoephedrine Theft of pharmaceutical products
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEXANDER DAHL | — |
| JAMES GERARD FLOOD | — |
| WILLIAM MOSCHELLA | — |
Health Issues HCR
Biosimilars; Pre-emption; Legal Reform; Importation; Health Care Reform S.525-Pharmaceutical Market Access and Drug Safety Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| JUDY BLACK | — |
| CATE MCCANLESS BLANKENBURG | — |
| ALEXANDER DAHL | — |
| REGINA E MAHONY | — |
| WILLIAM MOSCHELLA | — |
| ALFRED MOTTUR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.